View Older Stories

Jun 10, 2026 10:38AM Truist on Dianthus Therapeutics (DNTH) Amid Extreme Selloff: 'we believe the readthrough to DNTH should be limited'

Jun 10, 2026 07:21AM Dianthus Therapeutics (DNTH) Reiterated at Buy by Stifel

May 12, 2026 09:58AM Intellia short interest rises most among biotech stocks in latest period - Baird

May 5, 2026 05:27PM Dianthus Therapeutics (DNTH) Misses Q1 EPS by 85c

Apr 1, 2026 07:15AM William Blair Shuffles Analyst Conviction List for April 2026

Mar 26, 2026 10:54AM William Blair on Dianthus Therapeutics (DNTH): FDA removing ANA criteria 'an incremental positive'

Mar 19, 2026 05:23AM Wells Fargo Reiterates Overweight Rating on Dianthus Therapeutics (DNTH)

Mar 16, 2026 10:09AM William Blair Reiterates Outperform Rating on Dianthus Therapeutics (DNTH): 'should see multiple value inflection for shares'

Mar 10, 2026 04:16AM Raymond James Upgrades Dianthus Therapeutics (DNTH) to Strong Buy

Mar 9, 2026 05:28PM Dianthus Therapeutics (DNTH) PT Raised to $130 at Clear Street

Mar 9, 2026 03:51PM Dianthus Therapeutics (DNTH) PT Raised to $98 at Jefferies

Mar 9, 2026 02:55PM Dianthus Therapeutics (DNTH) 1300 contracts of May 70 puts trade, share price up 19.3%

Mar 9, 2026 11:49AM TD Cowen Reiterates Buy Rating on Dianthus Therapeutics (DNTH): "prime takeout target"

Mar 9, 2026 10:15AM Dianthus Therapeutics (DNTH) PT Raised to $145 at Oppenheimer

Mar 9, 2026 10:14AM Dianthus Therapeutics (DNTH) PT Raised to $120 at Stifel

Mar 9, 2026 08:11AM William Blair Reiterates Outperform Rating on Dianthus Therapeutics (DNTH): "remain bullish here"

Mar 9, 2026 08:09AM Guggenheim Reiterates Buy Rating on Dianthus Therapeutics (DNTH): Phase 3 "results exceeded our expectations"

Mar 9, 2026 07:44AM Dianthus Therapeutics (DNTH) Misses Q4 EPS by 143c

Mar 9, 2026 07:28AM Clear Street on Dianthus Therapeutics (DNTH): 'We view these data as de-risking'

Mar 9, 2026 07:26AM Dianthus Therapeutics (DNTH) PT Raised to $110 at Truist Securities

Mar 9, 2026 07:25AM Stifel on Dianthus Therapeutics (DNTH): 'today's update represents a best-case outcome, in our view'

Mar 4, 2026 05:10AM Dianthus Therapeutics (DNTH) PT Raised to $200 at Guggenheim

Jan 30, 2026 02:00PM This biotech stock is a Top Pick for 2026 at Oppenheimer

Jan 29, 2026 06:04AM Dianthus Therapeutics (DNTH) PT Raised to $125 at Oppenheimer

Jan 28, 2026 04:30PM Dianthus Therapeutics (DNTH) files $600M mixed shelf

Nov 10, 2025 06:48AM Dianthus Therapeutics (DNTH) PT Raised to $47 at H.C. Wainwright

Nov 5, 2025 06:02PM Dianthus Therapeutics (DNTH) Misses Q3 EPS by 97c

Oct 29, 2025 03:31PM Dianthus presents new data on claseprubart for myasthenia gravis

Oct 17, 2025 08:32AM Truist Securities: 'Is Biotech Back?!'

Oct 16, 2025 12:24PM Dianthus Therapeutics (DNTH) PT Raised to $60 at Oppenheimer

Oct 16, 2025 09:57AM TD Cowen on Dianthus (DNTH): 'the favorable economics of the deal will not impact prior guidance of cash runway into 2028'

Oct 16, 2025 09:56AM Guggenheim on Dianthus (DNTH) and Leads BioLabs Deal: 'We view this as a well-structured deal'

Oct 14, 2025 06:07AM Truist Securities Starts Dianthus Therapeutics (DNTH) at Buy

Sep 16, 2025 04:22PM Clear Street Starts Dianthus Therapeutics (DNTH) at Buy, PT $100

Sep 10, 2025 10:51AM Dianthus Therapeutics (DNTH) PT Raised to $66 at Jefferies, 'We believe DNTH is undervalued'

Sep 9, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Dianthus Therapeutics (DNTH)

Sep 9, 2025 05:04AM Dianthus Therapeutics (DNTH) PT Raised to $63 at Raymond James

Sep 8, 2025 12:19PM Dianthus Therapeutics (DNTH) PT Raised to $100 at Guggenheim

Sep 5, 2025 02:34PM Guggenheim on Dianthus Therapeutics (DNTH): 'remains one of our Top Picks'

Aug 22, 2025 07:15AM Cantor Fitzgerald Reiterates Overweight Rating on Dianthus Therapeutics (DNTH)

Aug 14, 2025 06:09AM Guggenheim Reiterates Buy Rating on Dianthus Therapeutics (DNTH)

Jul 28, 2025 06:11AM Dianthus Therapeutics (DNTH) PT Raised to $92 at Guggenheim

Jul 14, 2025 06:49AM Stifel Reiterates Buy Rating on Dianthus Therapeutics (DNTH)

Jul 2, 2025 06:02AM William Blair Starts Dianthus Therapeutics (DNTH) at Outperform

Jun 17, 2025 07:08AM Stifel Reiterates Buy Rating on Dianthus Therapeutics (DNTH)

May 22, 2025 04:10PM Dianthus Therapeutics (DNTH) Appoints Simon Read, Ph.D., to Board of Directors

May 13, 2025 06:57AM Dianthus Therapeutics (DNTH) Misses Q1 EPS by 82c

May 5, 2025 07:02AM Dianthus Therapeutics (DNTH) Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September

Mar 12, 2025 07:39AM Stifel Reiterates Buy Rating on Dianthus Therapeutics (DNTH)

Mar 12, 2025 06:33AM Dianthus Therapeutics (DNTH) Misses Q4 EPS by 81c

View Older Stories